Since its introduction to the market in 2012, Unyvero has been brought into numerous hospital laboratories and intensive care units throughout Europe. Leading clinical experts have tested the system and now appreciate the advantages of the Unyvero Solution in everyday clinical use.
Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China
Curetis secures financing facility of up to EUR 20 million through the issuance of convertible notes
38ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse - Paris, France - December 17 to 18, 2018
DIVI 2018- December 5 to 7, 2018, Leipzig, Germany